Matches in SemOpenAlex for { <https://semopenalex.org/work/W1549581926> ?p ?o ?g. }
- W1549581926 endingPage "7247" @default.
- W1549581926 startingPage "7241" @default.
- W1549581926 abstract "ABSTRACT Alpha interferon (IFN-α) treatment is effective on a long-term basis in only 15 to 25% of patients with chronic hepatitis C. The results of recent trials indicate that response rates can be significantly increased when IFN-α is given in combination with ribavirin. However, a large number of patients do not respond even to combination therapy. Nonresponsiveness to IFN is characterized by evolution of the hepatitis C virus (HCV) quasispecies. Little is known about the changes occurring within the HCV genomes when nonresponder patients are retreated with IFN or with IFN plus ribavirin. In the present study we have examined the genetic divergence of HCV quasispecies during unsuccessful retreatment with IFN or IFN plus ribavirin. Fifteen nonresponder patients with HCV-1 (4 patients with HCV-1a and 11 patients with HCV-1b) infection were studied while being retreated for 2 months (phase 1) with IFN-α (6 MU given three times a week), followed by IFN plus ribavirin or IFN alone for an additional 6 months (phase 2). HCV quasispecies diversification in the E2 hypervariable region-1 (HVR1) and in the putative NS5A IFN sensitivity determining region (ISDR) were analyzed for phase 1 and phase 2 by using the heteroduplex tracking assay and clonal frequency analysis techniques. A major finding of this study was the relatively rapid evolution of the HCV quasispecies observed in both treatment groups during the early phase 1 compared to the late phase 2 of treatment. The rate of quasispecies diversification in HVR1 was significantly higher during phase 1 versus phase 2 both in patients who received IFN plus ribavirin ( P = 0.017) and in patients who received IFN alone ( P = 0.05). A trend toward higher rates of quasispecies evolution in the ISDR was also observed during phase 1 in both groups, although the results did not reach statistical significance. However, the NS5A quasispecies appeared to be rather homogeneous and stable in most nonresponder patients, suggesting the presence of a single well-fit major variant, resistant to antiviral treatment, in agreement with published data which have identified an IFN sensitivity determinant region within the NS5A. During the entire 8 months of retreatment, there was no difference in the rate of fixation of mutation between patients who received combination therapy and patients who were treated with IFN alone, suggesting that ribavirin had no major effects on the evolution of the HCV quasispecies after the initial 2 months of IFN therapy." @default.
- W1549581926 created "2016-06-24" @default.
- W1549581926 creator A5004773206 @default.
- W1549581926 creator A5009411535 @default.
- W1549581926 creator A5014668744 @default.
- W1549581926 creator A5018741681 @default.
- W1549581926 creator A5059809028 @default.
- W1549581926 creator A5060507064 @default.
- W1549581926 creator A5080530216 @default.
- W1549581926 creator A5088417902 @default.
- W1549581926 date "1999-09-01" @default.
- W1549581926 modified "2023-10-09" @default.
- W1549581926 title "Effect of Retreatment with Interferon Alone or Interferon plus Ribavirin on Hepatitis C Virus Quasispecies Diversification in Nonresponder Patients with Chronic Hepatitis C" @default.
- W1549581926 cites W1656291587 @default.
- W1549581926 cites W1966049263 @default.
- W1549581926 cites W1978883570 @default.
- W1549581926 cites W2004651002 @default.
- W1549581926 cites W2006309458 @default.
- W1549581926 cites W2012647968 @default.
- W1549581926 cites W2017120662 @default.
- W1549581926 cites W2019932870 @default.
- W1549581926 cites W2029325114 @default.
- W1549581926 cites W2035566133 @default.
- W1549581926 cites W2041294723 @default.
- W1549581926 cites W2054966294 @default.
- W1549581926 cites W2078843265 @default.
- W1549581926 cites W2079317094 @default.
- W1549581926 cites W2087924794 @default.
- W1549581926 cites W2102942916 @default.
- W1549581926 cites W2109124959 @default.
- W1549581926 cites W2122088474 @default.
- W1549581926 cites W2122228848 @default.
- W1549581926 cites W2145355617 @default.
- W1549581926 cites W2148485291 @default.
- W1549581926 cites W2153307190 @default.
- W1549581926 cites W2162278804 @default.
- W1549581926 cites W2162552146 @default.
- W1549581926 cites W2318639814 @default.
- W1549581926 cites W2328171401 @default.
- W1549581926 cites W2335845212 @default.
- W1549581926 cites W2341829866 @default.
- W1549581926 cites W4294216491 @default.
- W1549581926 doi "https://doi.org/10.1128/jvi.73.9.7241-7247.1999" @default.
- W1549581926 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/104248" @default.
- W1549581926 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10438811" @default.
- W1549581926 hasPublicationYear "1999" @default.
- W1549581926 type Work @default.
- W1549581926 sameAs 1549581926 @default.
- W1549581926 citedByCount "58" @default.
- W1549581926 countsByYear W15495819262013 @default.
- W1549581926 countsByYear W15495819262016 @default.
- W1549581926 countsByYear W15495819262020 @default.
- W1549581926 crossrefType "journal-article" @default.
- W1549581926 hasAuthorship W1549581926A5004773206 @default.
- W1549581926 hasAuthorship W1549581926A5009411535 @default.
- W1549581926 hasAuthorship W1549581926A5014668744 @default.
- W1549581926 hasAuthorship W1549581926A5018741681 @default.
- W1549581926 hasAuthorship W1549581926A5059809028 @default.
- W1549581926 hasAuthorship W1549581926A5060507064 @default.
- W1549581926 hasAuthorship W1549581926A5080530216 @default.
- W1549581926 hasAuthorship W1549581926A5088417902 @default.
- W1549581926 hasBestOaLocation W15495819261 @default.
- W1549581926 hasConcept C14500911 @default.
- W1549581926 hasConcept C159047783 @default.
- W1549581926 hasConcept C159654299 @default.
- W1549581926 hasConcept C203014093 @default.
- W1549581926 hasConcept C2522874641 @default.
- W1549581926 hasConcept C2776178377 @default.
- W1549581926 hasConcept C2776408679 @default.
- W1549581926 hasConcept C2776455275 @default.
- W1549581926 hasConcept C2777103181 @default.
- W1549581926 hasConcept C2780040827 @default.
- W1549581926 hasConcept C2780727368 @default.
- W1549581926 hasConcept C2781463415 @default.
- W1549581926 hasConcept C2909179924 @default.
- W1549581926 hasConcept C81566733 @default.
- W1549581926 hasConcept C86803240 @default.
- W1549581926 hasConceptScore W1549581926C14500911 @default.
- W1549581926 hasConceptScore W1549581926C159047783 @default.
- W1549581926 hasConceptScore W1549581926C159654299 @default.
- W1549581926 hasConceptScore W1549581926C203014093 @default.
- W1549581926 hasConceptScore W1549581926C2522874641 @default.
- W1549581926 hasConceptScore W1549581926C2776178377 @default.
- W1549581926 hasConceptScore W1549581926C2776408679 @default.
- W1549581926 hasConceptScore W1549581926C2776455275 @default.
- W1549581926 hasConceptScore W1549581926C2777103181 @default.
- W1549581926 hasConceptScore W1549581926C2780040827 @default.
- W1549581926 hasConceptScore W1549581926C2780727368 @default.
- W1549581926 hasConceptScore W1549581926C2781463415 @default.
- W1549581926 hasConceptScore W1549581926C2909179924 @default.
- W1549581926 hasConceptScore W1549581926C81566733 @default.
- W1549581926 hasConceptScore W1549581926C86803240 @default.
- W1549581926 hasIssue "9" @default.
- W1549581926 hasLocation W15495819261 @default.
- W1549581926 hasLocation W15495819262 @default.
- W1549581926 hasLocation W15495819263 @default.
- W1549581926 hasLocation W15495819264 @default.
- W1549581926 hasOpenAccess W1549581926 @default.